| Pharmaceutical Information |
| Drug Name |
Monobenzone |
| Drug ID |
BADD_D01493 |
| Description |
Monobenzone is the monobenzyl ether of hydroquinone used medically for depigmentation. Monobenzone occurs as a white, almost tasteless crystalline powder, soluble in alcohol and practically insoluble in water. It exerts a depigmenting effect on skin of mammals by increasing the excretion of melanin from the melanocytes. It may also cause destruction of melanocytes and permanent depigmentation. |
| Indications and Usage |
Used topically to treat the loss of skin color (vitiligo). |
| Marketing Status |
Discontinued |
| ATC Code |
D11AX13 |
| DrugBank ID |
DB00600
|
| KEGG ID |
D05072
|
| MeSH ID |
C006429
|
| PubChem ID |
7638
|
| TTD Drug ID |
D0H6TP
|
| NDC Product Code |
71052-111; 73309-070 |
| Synonyms |
monobenzone | hydroquinone monobenzyl ether | agerite alba | monobenzyl ether hydroquinone | p-(benzyloxy)phenol | Benoquin | Novo-depigman |
|
| Chemical Information |
| Molecular Formula |
C13H12O2 |
| CAS Registry Number |
103-16-2 |
| SMILES |
C1=CC=C(C=C1)COC2=CC=C(C=C2)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
